More recently, we analyzed the repertoire of CD4 T cells recognizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in previously unexposed individuals (7) due to the potential implications of preexisting immunity in the modulation of coronavirus disease 2019 (COVID-19) severity (8, 9). This evidence concerns the gene CD4 and COVID-19.